Bavarian Nordic

Bavarian Nordic, headquartered in Denmark and operating in Pharmaceutical Preparation Manufacturing, reported total emissions of about 58,187,000 kg CO2e in 2025. This includes approximately 3,218,000 kg CO2e from Scope 1, 1,130,000 kg CO2e from Scope 2 (location-based), and 54,616,000 kg CO2e from Scope 3. Key contributors to Scope 3 emissions were purchased goods and services (about 33,385,000 kg CO2e), capital goods (approximately 6,580,000 kg CO2e), and waste generated in operations (around 5,230,000 kg CO2e).

In 2024, the company's total emissions were approximately 53,264,000 kg CO2e, comprising about 3,519,000 kg CO2e from Scope 1, 1,715,000 kg CO2e from Scope 2 (location-based), and 45,031,000 kg CO2e from Scope 3.

Looking back to 2023, Bavarian Nordic's total emissions stood at about 97,706,000 kg CO2e, with Scope 1 emissions of approximately 4,364,000 kg CO2e, Scope 2 (location-based) emissions of about 3,038,000 kg CO2e, and Scope 3 emissions of around 87,024,000 kg CO2e.

Bavarian Nordic has committed to achieving Net Zero emissions by no later than 2050, in alignment with the Paris Agreement on Climate Change. As part of this commitment, the company plans to define its carbon footprint reduction pathway in 2024. Bavarian Nordic has also communicated a near-term target status of "Committed" with the Science Based Targets initiative (SBTi).